Remove Bioinformatics Remove Drugs Remove Life Science Remove Pharma Companies
article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . The post Digitalising drug discovery appeared first on.

article thumbnail

How digital is transforming the commercial leader’s role in biopharma

pharmaphorum

A range of pharma leaders is critical to realising these new digital opportunities, including IT, regulatory, data, digital, and R&D heads. However, pharma’s commercial leaders are uniquely positioned to drive the strategic digital shift in patient care journeys. Then, they can scale the lessons across a broader drug portfolio.

Marketing 132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

data processing systems that support bioinformatics modelling) and digital record systems (e.g. However, if considered early in the drug development plan, compliance is by no means insurmountable and would be offset by the benefits of digital healthcare tools for patient engagement. video consultations), health data analytics (e.g.

article thumbnail

Big pharma companies partner to form AI-based start-up

pharmaphorum

Built under a government tender, AION Labs comprises four large international pharma companies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. The post Big pharma companies partner to form AI-based start-up appeared first on. The partnership. About the author .

article thumbnail

Open science, genomics, and the quiet revolution in our approach to pharma

Drug Discovery World

The tide has been turning in the worlds of diagnostics and drug development. Bioinformatics and genetic sequencing are starting to be placed front and centre of public research programmes as scientists from around the world recognise the substantial benefits of knowledge sharing and resource pooling when it comes to genetic science.

Genome 52
article thumbnail

Top 10 Fastest Growing Biotech Companies in 2023

XTalks

Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times. million and $38.8 million, respectively, as compared to $17.6

Genetics 111
article thumbnail

GSK’s Maria Reyes Boceta-Muñoz Talks Vaccine Development in a Post-Pandemic World

XTalks

To address cultural considerations, it is essential that pharma companies work together with healthcare providers to promote trust in vaccines. Now, the focus has changed, and there is a new challenge for pharma and computer industry partnerships to develop AI-enabled clinical trial technologies or platforms.